Drug Database
Back to search

Belgium· BE-AMP-SAM427165-00

Mycosten 10 mg/g

A ciclopirox product containing ciclopirox olamine, registered in Belgium by Pierre Fabre Benelux. The same ATC class is registered in 12 of our 19 countries.

ATC D01AE14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMycosten 10 mg/gATCD01AE14REGISTER NO.BE-AMP-SAM427165-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ciclopirox olamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ciclopirox is registered in 12 of 19 countries.

Countries holding a registration under ATC D01AE14 (ciclopirox), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search ciclopirox products by name

Ciclopirox · ATC D01AE14

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciclopirox costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from <$0.001 in Czechia to $2.04 in Switzerland — a ×4085 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ciclopirox · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.04
  • CZ Czechia<$0.001
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ciclopirox Olamine
Manufacturer
Pierre Fabre Benelux
Country
Belgium (BE)
ATC code
D01AE14
ATC class
Ciclopirox
Defined daily dose
20 mg, T
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2991826

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

118 interactions on record for ciclopirox.

Graded by severity as the source publishes them — 118 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ciclopirox against other medicinesHow interaction checks work

Ciclopirox · interactions on record

118 records

  • 118 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Ciclopirox in 7 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All ciclopirox products

    Authorised across Europe · EMA

    The same active substance is authorised in 16 EEA countries. Names it is sold under:

    • Cyprus · Mycomycen
    • Czechia · Batrafen, Dafnegin
    • Germany · Batrafen, Ciclocutan
    • Spain · Capitec, Ciclochem
    • France · Ciclopirox Olamine Arrow, Ciclopirox Olamine Biogaran
    • Greece · Mycomycen, Neo-Botacreme
    • Croatia · Oxolam
    • Hungary · Batrafen
    • Ireland · Stieprox
    • Italy · Bioginal, Dafnegin
    • Luxembourg · Mycoster
    • Malta · Mycoskin
    • Netherlands · Loprox
    • Poland · Ciclopirox Ziaja, Dafnegin
    • Portugal · Mycoster
    • Slovakia · Batrafen

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/54f0262e-bb39-4c89-b93f-93fddb7728ea
GET /v1/drugs/54f0262e-bb39-4c89-b93f-93fddb7728ea?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Cream",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Mycosten 10 mg/g",
  "name_fr": "Mycosten 10 mg/g",
  "name_nl": "Mycosten 10 mg/g",
  "amp_code": "SAM427165-00",
  "strengths": [
    "1.0000",
    "1.0000",
    "1.0000",
    "5.7500",
    "3.5000",
    "5.7500"
  ],
  "pack_count": 1,
  "substances": [
    "Ciclopirox Olamine",
    "Benzyl Alcohol",
    "Cetyl Alcohol",
    "Polysorbate 60",
    "Stearyl Alcohol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ciclopirox",
  "authorisation_numbers": [
    "BE427165"
  ]
}
    API referenceMCP serverPlans

    See everything about ciclopirox.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console